New test uses PAM50 breast cancer gene signature discovered by UNC’s Perou
Physicians experience increased effort, uncertainty in cross-coverage of radiation oncology patients
Radiation oncology physicians who encounter an unfamiliar case when cross-covering for another physician experience higher levels of perceived workload and may also affect performance, according to research conducted at the University of North Carolina.
Abiraterone acetate, a recently FDA-approved drug used to treat men with metastatic castration-resistant prostate cancer, significantly delays progression of pain and quality of life deterioration when taken in conjunction with prednisone.
Dr. Cynthia Powell of N.C. Children's Hospital and Dr. Jonathan Berg of UNC Lineberger Comprehensive Cancer Center will answer your questions in a live Facebook chat at noon (12 p.m.) Eastern time on Thursday, Sept. 26.
Research from new programs to inform potential tobacco regulatory activities
An 82-year-old resident of Aurora, N.C., is referred to UNC Hospitals for treatment of a nasal cavity cancer in the post of tissue between his nostrils. A multidisciplinary treatment decision, the support of his family and a stay at SECU Family House see him through.
Researchers at UNC plan to sequence the entire genome of 400 infants to determine what useful clinical data can be acquired through the tests.
As a clinical nurse IV in the outpatient clinics of N.C. Cancer Hospital, Collier plays many roles from nurse manager to caring for patients. He's used to playing different roles though as he's been into drama and theater about as long as he's been in nursing.
Dr. Sharpless succeeds H. Shelton “Shelley” Earp, MD, as center director. Dr. Earp will continue as director of UNC Cancer Care, a role in which he coordinates cancer care and research across the School of Medicine, the University and UNC Health Care System.
The research team included Dr. Paul Godley of the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center.
This study shows that cell mobility occurs through the interactions between the protein vinculin and the cytoskeletal lattice formed by the protein actin.
The laboratory has provided an invaluable service to patients and has also built capacity at a national teaching hospital, according to an analysis of the first 20 months of operation published online by PLOS ONE.
RNA diagnostic test from paraffin improves lung cancer diagnosis over routine microscopic evaluation alone
Scientists at the Universities of North Carolina and Utah have developed a histology expression predictor for the most common types of lung cancer: adenocarcinoma, carcinoid, small cell carcinoma and squamous cell carcinoma.
A 65-year-old Person County man is successfully treated for a rare head and neck cancer, but the treatment side effects damaged his teeth and gums. He may have lost his pearly whites, but not his spirit or his faith.
Scientists found that among white women, household size and losing a job due to one's diagnosis were reasons for delay in treatment, while among African-American women, the type of treatment received influenced delay.
About half of the obstetrician-gynecologists surveyed in a recent study said they continue to provide annual exams. Drs. Russell Harris and Stacey Sheridan of UNC say this is an outdated practice that may be more harmful than helpful.
New evidence by a UNC-led team shows that MerTK macrophage action in the microenvironment that surrounds cancer cells blunts the immune response, allowing the tumor cell to grow and metastasize.
A UNC research team found that genetically engineered mouse models (GEMMs) were able to accurately predict human response to a standard chemotherapy drug combination commonly used in the clinic.
Dr. Ethan Basch of UNC calls for pharmaceutical manufacturers to collect rigorous information on how drugs impact symptoms and quality of life starting early in drug development, and for the U.S. Food and Drug Administration (FDA) to include this information in drug labels.
A team of scientists from the University of North Carolina School of Medicine, North Carolina State University’s College of Veterinary Medicine and Duke University have conducted one of the first studies to directly compare canine and human B-cell lymphoma by examining molecular similarities and differences between the two species.